John Reynolds
@Dr_JohnR
Rheumatologist and lupus researcher in Birmingham, UK. Occasional baker of cakes.
A moment for some of our wonderful patients who make research possible and in doing so are improving the future of healthcare for generations to come🏥✨😀 #healthcare #research #nhs
We have a funded PhD opportunity to study patient preferences in the treatment of #lupus #nephritis using mixed methods. @InflamAge_UoB @DrMarieFalahee birmingham.ac.uk/study/postgrad…
New video about the @unibirmingham 125th Anniversary fully funded PhD scholarships for Black British Researchers lnkd.in/e8BWUdej. Still open for applications - including ours: tinyurl.com/24n8jjmw @BPSOfficial @divhealthpsych @UoB_SoP @unibirm_CMH
PhD applications open for UoB's 125th anniversary scholarships, an initiative designed to empower and support Black British researchers in their pursuit of doctoral education. Details: birmingham.ac.uk/study/postgrad… @BEMA_Online @unibirmingham @LES_UniBham @UBSportExR
Applications open for the University of Birmingham's 125th anniversary scholarship programme to support Black British researchers in their pursuit of doctoral education. Deadline for applications: Wednesday 30 April 2025 @Dr_JohnR @UBSportExR jobs.ac.uk/job/DLY103/125…
PhD applications open for Black British Researchers at UoB. Project Title: Examining the impact of physical activity and sedentary behaviour on the clinical health of people with Lupus. birmingham.ac.uk/study/postgrad… Please contact me for more information: [email protected]
Cutaneous vasculitis in #lupus tends to occur early, can recur, and may be associated with more severe disease tinyurl.com/42v6py3v #SLE @InflamAge_UoB
Review by #mumpredict and team highlighting pregnancy complications might lead to development of autoimmune diseases in women.@Krishnarajah @JingyaWang815 @StevenWambua @anuradhaa_s @Dr_JohnR @AFFFazla1
Systematic review of the associations between autoimmune diseases and pregnancy complications Read the full study here: bmcmedicine.biomedcentral.com/articles/10.11… by @Nirantharakumar @StevenWambua @meghasingh_16 and colleagues
Delighted to launch the first part of our @RheumatologyUK study which aims to support #Rheumatology healthcare professionals to write ✍️directly to patients All #UK rheumatology #patients please complete our #survey! 👀 bit.ly/W2Pptsurvey 📢 Please share!
NEW SURVEY: We are looking for current patients of #Rheumatology outpatient departments in the UK NHS/HSC. We want to know what you think about clinic letters and who they are written to. To complete our survey, or for more information, please visit: bit.ly/W2Pptsurvey
absolute highlight of my conference #EULAR24 was meeting with fantastic researchers in #SLE for the #ELUSIDATE project❤️ @Yuz6Yusof @IoannisParodis @m_scherlinger @sarahdyball1 @piantoni_silvia @ivan_padjen @DrJohnReynolds
Fantastic presentation from @MiaRodziewicz using BILAG-BR data: ⭐️NPSLE had higher damage / disease activity ⭐️ NPSLE more likely to have APS ab ⭐️ RTX appears effective in NPSLE (no trials)
Naturally occurring peptide PEPITEM holds therapeutic promise for osteoporosis and bone loss Paper bit.ly/3wIKths Press release bit.ly/3QPudSQ @McGettrickLab @VersusArthritis @InflamAge_UoB @unibirm_MDS @BSRAgeing @ndorms @The_MRC @DrJamesEd @CellRepMed
💥Significant proportion of CTD patients are excluded from Ph3 clinical trials 💥Classification criteria may take several years to be adopted into trial protocols 💥Stringent trial eligibility may lead to poor generalisability for real-world patients 👇 sciencedirect.com/science/articl…
📢CALLING all patients with Lupus 🦋 🗣️Your voice matters! 👉 Participate in our LUPPOS survey to help us better understand your attitudes towards steroids used in SLE treatment ⬇️Links available in comments @LupusEurope @Felupus @LupusMadrid @Lupusreference @lupuscyclopedia
#Lupus is an autoimmune disease that affects nearly 500,000 people in Europe and over 5 million people in the world. It affects not only patients but also their loved ones. Let's raise awareness of the importance of an early diagnosis #WorldLupusDay #MakeLupusVisible #Lupus100"
Today is #WorldLupusDay! 💜 Lupus is a chronic autoimmune disorder where the immune system of the body attacks itself, affecting around 1 in 1,000 people living in the UK. Learn more about #lupus at lupusuk.org.uk #MakeLupusVisible #LupusAwareness #LUPUSUK
Do rheumatologists and nephrologists have different preferred treatment approaches for #lupus nephritis? (Short answer, yes) @RRG_Birmingham @InflamAge_UoB rb.gy/tuqyqs
NIHR Academic Clinical Lecturer post in Brum out for advert 👇 🙌 edzz.fa.em3.oraclecloud.com/hcmUI/Candidat…
Important research from @Dr_JohnR and colleagues highlighting the differences in management approaches for #lupus nephritis within the UK and that rituximab remains the most popular choice for refractory renal disease academic.oup.com/rheumap/articl…